Synopsis of recent research by authors named "Ana Luiza Mansur"
- Ana Luiza Mansur's research primarily focuses on the development of innovative formulations of amphotericin B (AmB) to enhance its efficacy and reduce nephrotoxicity in the treatment of systemic fungal infections and leishmaniasis.
- Her 2022 study investigates a novel granule form of AmB (AmB-NP-GR) that utilizes nanotechnology to improve safety profiles, making it a potential option for outpatient treatment of infections traditionally confined to hospital settings.
- In her 2020 research, she evaluated the in vitro and in vivo efficacy of a pH-sensitive amphotericin B-loaded nanostructured lipid carrier (AmB-NLC), demonstrating its promise as a more effective and safer therapeutic option for treating leishmaniasis, which is often underfunded and overlooked in terms of treatment options.